safety issues with China-made syringes more widespread than initially known

[Pelican Press 0]

safety issues with China-made syringes more widespread than initially known

The U.S. Food and ***** Administration’s Center for Devices and Radiological Health

This is the hidden content, please

• Sign In
• or
• Sign Up

that ********-made plastic syringes that are distributed in the U.S. have “more widespread” quality control issues than were previously known.

In a

This is the hidden content, please

• Sign In
• or
• Sign Up

Tuesday, the FDA said it found three ******** syringe manufacturers were in violation of its regulations.

CNBC has been investigating the issue since November, when the

This is the hidden content, please

• Sign In
• or
• Sign Up

it was reviewing reports of quality and performance issues with these syringes, including leaks and breakage. After CNBC had been inquiring about the issue for months, the agency released an

This is the hidden content, please

• Sign In
• or
• Sign Up

safety communication and its Center for Devices and Radiological Health published a release stating its ongoing evaluation “has confirmed that issues with the quality of plastic syringes made in China and their distribution in the U.S. are more widespread than originally known.”

In its safety communication, the FDA said that on Monday, it sent warning letters to three ******** manufacturers:

This is the hidden content, please

• Sign In
• or
• Sign Up

, a China-based manufacturer of plastic syringes, as well as

This is the hidden content, please

• Sign In
• or
• Sign Up

and

This is the hidden content, please

• Sign In
• or
• Sign Up

, two firms marketing and distributing plastic syringes made in China within the U.S. The letters cite violations related to the ***** and distribution of unauthorized plastic syringes made in China that are not cleared by the FDA for use in the U.S. 

In a January statement to CNBC, the agency wrote that in 2023, it received more than 4,000 reports regarding plastic syringe issues, adding that this figure was not limited to just syringes manufactured in China. The agency further wrote that there were “limitations” to this data, such as “incomplete information in the reports” and “potential under-reporting.”

As part of its monthslong investigation, CNBC reviewed hundreds of narratives for syringe medical device reports, or MDRs, which are submissions to the FDA designed to highlight suspected issues or malfunctions associated with medical products.

In the reports CNBC reviewed, which looked at manufacturers beyond those issued the recent warning letters, some customers and physicians say they found “

This is the hidden content, please

• Sign In
• or
• Sign Up

” in syringes. Others said they had “

This is the hidden content, please

• Sign In
• or
• Sign Up

break off in the vials when drawing up vaccines,” “

This is the hidden content, please

• Sign In
• or
• Sign Up

delivering faster than it should,” and that the syringes were “

This is the hidden content, please

• Sign In
• or
• Sign Up

,” among other issues. In one

This is the hidden content, please

• Sign In
• or
• Sign Up

for Jiangsu Shenli Medical Production, which was one of the manufacturers given a warning letter, a customer reported the syringe was causing “an inaccurate measurement of vaccine.”

The three companies issued warning letters did not immediately respond to CNBC’s request for comment. 

According to the FDA’s medical device reporting

This is the hidden content, please

• Sign In
• or
• Sign Up

, Jiangsu Shenli Medical Production and Sol-Millennium Medical produce plastic syringes for McKesson, a major pharmaceutical manufacturer headquartered in Irving, Texas. 

This is the hidden content, please

• Sign In
• or
• Sign Up

the FDA wrote that U.S. suppliers, consumers and health-care organizations should “immediately transition away” from using plastic syringes manufactured by Jiangsu Caina Medical Co. Ltd. and unauthorized plastic syringes manufactured by Jiangsu Shenli Medical Production unless “absolutely necessary.” In regard to all other plastic syringes manufactured in China, the agency said that they should be used as needed until a transition to another product is possible, and urged that users should monitor for defects. 

McKesson did not immediately respond to a request for comment.

In addition to Jiangsu Shenli Medical Production and Sol-Millennium Medical, there are other China-based manufacturers that produce plastic syringes for McKesson, according to FDA data. Medical device reports also link

This is the hidden content, please

• Sign In
• or
• Sign Up

,

This is the hidden content, please

• Sign In
• or
• Sign Up

,

This is the hidden content, please

• Sign In
• or
• Sign Up

and

This is the hidden content, please

• Sign In
• or
• Sign Up

to McKesson.

McKesson isn’t the only pharmaceutical giant facing issues with its syringes.

This is the hidden content, please

• Sign In
• or
• Sign Up

and

This is the hidden content, please

• Sign In
• or
• Sign Up

have also had class one recalls — the most serious type of recall — for their syringes in the past several months. According to the recall, the size changes in Cardinal Health Monoject syringes when used with various pumps caused problems such as incorrect dosages, therapy delays and pump malfunctions, including occlusion alarms and feeding delays. In a

This is the hidden content, please

• Sign In
• or
• Sign Up

from February, Cardinal Health said its goal is to provide “safe, high-quality products” and it has not received received any reports of patient ****** due to these syringes, but added “there is a potential risk of serious injury or ******.”

The FDA said Fresenius recalled its product due to reports of syringe leakage as well as reports of unknown ****** material inside the syringe. In a November

This is the hidden content, please

• Sign In
• or
• Sign Up

, Fresenius said it sent recall notifications to 1,699 customers about its voluntary removal of its syringe products from the market. 

In its statement to CNBC, the FDA said it believes the supply and manufacturing capability of plastic syringes made in countries other than China, including in the U.S., is sufficient to prevent a shortage. The agency also said it will continue to evaluate problems with syringes made in China.

This is the hidden content, please

• Sign In
• or
• Sign Up

******* States,China,Health care industry,Biotech and Pharmaceuticals,Mckesson Corp,business news
#safety #issues #Chinamade #syringes #widespread #initially

This is the hidden content, please

• Sign In
• or
• Sign Up